248 related articles for article (PubMed ID: 16285529)
21. Cell surface expression of a human IgG Fc chimera activates macrophages through Fc receptors.
Stabila PF; Wong SC; Kaplan FA; Tao W
Nat Biotechnol; 1998 Dec; 16(13):1357-60. PubMed ID: 9853619
[TBL] [Abstract][Full Text] [Related]
22. Controlled growth of Chinese hamster ovary cells and high expression of antibody-IL-2 fusion proteins by temperature manipulation.
Shi M; Xie Z; Yu M; Shen B; Guo N
Biotechnol Lett; 2005 Dec; 27(23-24):1879-84. PubMed ID: 16328984
[TBL] [Abstract][Full Text] [Related]
23. Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
White DM; Jensen MA; Shi X; Qu Zx ; Arnason BG
Protein Expr Purif; 2001 Apr; 21(3):446-55. PubMed ID: 11281720
[TBL] [Abstract][Full Text] [Related]
24. Binding activity difference of anti-CD20 scFv-Fc fusion protein derived from variable domain exchange.
Geng SS; Feng J; Li Y; Sun Y; Gu X; Huang Y; Wang Y; Kang X; Chang H; Shen B
Cell Mol Immunol; 2006 Dec; 3(6):439-43. PubMed ID: 17257497
[TBL] [Abstract][Full Text] [Related]
25. [Construction of BPI23-Fc gamma 1 recombinant protein prokaryotic expression vector and the expression and biological assessment of BPI23-Fc gamma 1 recombinant protein].
An Y; Ke Y; Yang G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):511-6. PubMed ID: 12903392
[TBL] [Abstract][Full Text] [Related]
26. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
[TBL] [Abstract][Full Text] [Related]
27. [Expression of mouse B7-H3-Fc fusion protein and characterization of its bioactivity].
Yan RH; Zhang GB; Sun J; Fu FQ; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1067-9. PubMed ID: 21055342
[TBL] [Abstract][Full Text] [Related]
28. [Construction and expression of a fusion protein containing extracellular domain of human Jagged1 and Fc fragment of human IgG1].
Jia HX; Zhang P; Zhou P; Han H; Liang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):278-81. PubMed ID: 15193217
[TBL] [Abstract][Full Text] [Related]
29. [Expression pattern and level of cytotoxic T lymphocyte-associated antigen-4 targeted anti-caries plasmids in eukaryotic cells].
Guo JH; Fan MW; Jia R; Bian Z; Chen Z; Yu F
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 May; 41(5):272-4. PubMed ID: 16784605
[TBL] [Abstract][Full Text] [Related]
30. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
[TBL] [Abstract][Full Text] [Related]
31. [Construction and expression of a fusion protein containing extracellular domain of human Jagged1 and Fc fragment of human IgG1 in Pichia Pastoris].
Li GH; Kang ZJ; Huang SY; He F; Xu H; Zhang L; Wu YL; Niu XL; Ma CS; Han H; Liang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):910-4. PubMed ID: 18718088
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture.
Bender E; Woof JM; Atkin JD; Barker MD; Bebbington CR; Burton DR
Hum Antibodies Hybridomas; 1993 Apr; 4(2):74-9. PubMed ID: 8518367
[TBL] [Abstract][Full Text] [Related]
33. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
34. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors.
Martyn JC; Cardin AJ; Wines BD; Cendron A; Li S; Mackenzie J; Powell M; Gowans EJ
Arch Virol; 2009; 154(7):1129-38. PubMed ID: 19557497
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.
Duan HF; Hu XW; Chen JL; Gao LH; Xi YY; Lu Y; Li JF; Zhao SR; Xu JJ; Chen HP; Chen W; Wu CT
J Natl Cancer Inst; 2007 Oct; 99(20):1551-5. PubMed ID: 17925540
[TBL] [Abstract][Full Text] [Related]
36. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
37. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
[TBL] [Abstract][Full Text] [Related]
38. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
39. Oligomerization is required for the activity of recombinant soluble LOX-1.
Cao W; Calabro V; Root A; Yan G; Lam K; Olland S; Sanford J; Robak A; Zollner R; Lu Z; Ait-Zahra M; Agostinelli R; Tchistiakova L; Gill D; Harnish D; Paulsen J; Shih HH
FEBS J; 2009 Sep; 276(17):4909-20. PubMed ID: 19664054
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human lactoferrin-Fc fusion with an improved plasma half-life.
Shiga Y; Oshima Y; Kojima Y; Sugimoto A; Tamaki N; Murata D; Takeuchi T; Sato A
Eur J Pharm Sci; 2015 Jan; 67():136-143. PubMed ID: 25433245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
